Thyrocare Technologies Ltd Share Price ₹529

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Thyrocare Technologies Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	136	135	148	135	154	157	177	166	187	193	217	196	224
Expenses +	111	100	110	103	121	115	129	124	130	135	145	138	149
Operating Profit	25	35	38	32	34	42	48	42	57	58	71	58	75
OPM %	18%	26%	25%	23%	22%	27%	27%	25%	30%	30%	33%	30%	34%
Other Income +	4	1	3	3	3	4	3	4	5	5	3	-1	5
Interest	1	1	1	1	1	1	1	1	1	1	1	-0	2
Depreciation	11	10	11	13	13	11	13	17	14	11	12	22	14
Profit before tax	17	25	28	20	23	34	37	28	47	50	63	35	64
Tax %	28%	31%	28%	26%	25%	29%	28%	32%	54%	24%	24%	21%	24%
Net Profit +	12	17	20	15	17	24	26	19	22	38	48	28	49
EPS in Rs	0.79	1.09	1.28	0.97	1.12	1.52	1.68	1.20	1.36	2.45	3.02	1.82	2.96

Financials of Thyrocare Technologies Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	183	241	304	356	403	434	495	589	527	572	687	829
Expenses +	110	147	189	212	249	261	323	353	403	432	498	567
Operating Profit	73	94	115	145	154	174	171	236	123	140	190	262
OPM %	40%	39%	38%	41%	38%	40%	35%	40%	23%	24%	28%	32%
Other Income +	8	7	-15	21	11	1	12	29	9	9	15	12
Interest	0	1	0	0	1	2	1	3	5	6	4	3
Depreciation	13	18	18	20	26	32	30	34	39	47	55	59
Profit before tax	68	82	82	145	138	140	152	228	89	96	145	213
Tax %	35%	37%	48%	36%	38%	37%	26%	23%	27%	28%	38%	24%
Net Profit +	44	52	43	93	85	88	113	176	64	69	91	163
EPS in Rs	2.98	3.21	2.66	5.79	5.38	5.58	7.13	11.10	4.06	4.45	5.76	10.24
Dividend Payout %	171%	104%	125%	58%	124%	30%	117%	45%	148%	135%	122%	0%

Financials of Thyrocare Technologies Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	51	54	54	54	53	53	53	53	53	53	53	159
Reserves	226	312	354	390	382	314	374	474	481	474	494	426
Borrowings +	0	0	0	0	2	12	8	21	23	42	25	51
Other Liabilities +	53	44	30	36	37	90	106	60	74	75	121	111
Total Liabilities	329	410	438	479	475	469	541	607	632	644	693	747
Fixed Assets +	196	259	259	299	294	269	253	285	294	306	297	317
CWIP	6	1	17	0	1	5	8	3	2	3	14	3
Investments	86	93	104	120	95	90	126	146	144	162	162	177
Other Assets +	42	56	58	60	84	105	154	173	192	173	220	250
Total Assets	329	410	438	479	475	469	541	607	632	644	693	747

Financials of Thyrocare Technologies Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	34	68	90	107	100	168	115	113	129	168	191	213
Cash from Investing Activity +	-18	-18	-42	-43	-12	1	-49	-24	-39	-91	-53	-23
Cash from Financing Activity +	-23	-45	-49	-64	-94	-165	-62	-89	-86	-85	-130	-170
Net Cash Flow	-6	5	-0	-0	-5	4	4	0	4	-8	8	21
Free Cash Flow	25	53	53	63	61	158	93	99	88	107	146	198
CFO/OP	79%	106%	113%	108%	104%	122%	92%	72%	128%	141%	123%	104%

Financials of Thyrocare Technologies Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	10	11	8	10	11	14	33	58	59	28	39	33
Inventory Days	48	56	65	66	60	64	52	53	62	104	89	81
Days Payable	5	10	6	25	25	68	56	36	54	88	146	109
Cash Conversion Cycle	53	57	67	50	46	10	29	75	67	44	-18	4
Working Capital Days	28	2	19	10	28	-8	19	41	31	7	13	86
ROCE %		24%	28%	33%	30%	35%	36%	42%	17%	18%	25%	37%